| Phenotype frequencies of blood group systems (Rh, Kell, Kidd, Duffy, MNS, P, Lewis, and Lutheran) in north Indian blood donors B Thakral, K Saluja, RR Sharma, N Marwaha Transfusion and Apheresis Science 43 (1), 17-22, 2010 | 156 | 2010 |
| EBV-positive mucocutaneous ulcer in organ transplant recipients: a localized indolent posttransplant lymphoproliferative disorder M Hart, B Thakral, S Yohe, HH Balfour Jr, C Singh, M Spears, ... The American journal of surgical pathology 38 (11), 1522-1529, 2014 | 151 | 2014 |
| Red cell alloimmunization in a transfused patient population: a study from a tertiary care hospital in north India B Thakral, K Saluja, RR Sharma, N Marwaha Hematology 13 (5), 313-318, 2008 | 104 | 2008 |
| DDX41 mutations in myeloid neoplasms are associated with male gender, TP53 mutations and high‐risk disease AE Quesada, MJ Routbort, CD DiNardo, CE Bueso‐Ramos, ... American journal of hematology 94 (7), 757-766, 2019 | 93 | 2019 |
| Clinicopathologic features and prognostic impact of lymph node involvement in patients with breast implant-associated anaplastic large cell lymphoma MC Ferrufino-Schmidt, LJ Medeiros, H Liu, MW Clemens, KK Hunt, ... The American journal of surgical pathology 42 (3), 293, 2018 | 86 | 2018 |
| Nivolumab combined with ibrutinib for CLL and Richter transformation: a phase II trial N Jain, S Basu, PA Thompson, M Ohanian, A Ferrajoli, N Pemmaraju, ... Blood 128 (22), 59, 2016 | 68 | 2016 |
| Anti-HBc screening in Indian blood donors: Still an unresolved issue HK Dhawan, N Marwaha, RR Sharma, Y Chawla, B Thakral, K Saluja, ... World journal of gastroenterology: WJG 14 (34), 5327-5350, 2008 | 68 | 2008 |
| Prevalence & significance of hepatitis C virus (HCV) seropositivity in blood donors B Thakral, N Marwaha, YK Chawla, K Saluja, A Sharma, RR Sharma, ... Indian Journal of Medical Research 124 (4), 431-438, 2006 | 68 | 2006 |
| Importance of weak ABO subgroups B Thakral, K Saluja, M Bajpai, RR Sharma, N Marwaha Laboratory Medicine 36 (1), 32-34, 2005 | 56 | 2005 |
| Prognostic impact of CD 5 expression in diffuse large B‐cell lymphoma in patients treated with rituximab‐EPOCH B Thakral, LJ Medeiros, P Desai, P Lin, CC Yin, G Tang, JD Khoury, S Hu, ... European Journal of Haematology 98 (4), 415-421, 2017 | 55 | 2017 |
| First report from India of haemolytic disease of newborn by anti-c and anti-E in Rh (D) positive mothers B Thakral, S Agrawal, H Krishan Dhawan, K Saluja, S Dutta, N Marwaha Hematology 12 (5), 377-380, 2007 | 54 | 2007 |
| High-grade B-cell lymphomas with TdT expression: a diagnostic and classification dilemma CY Ok, LJ Medeiros, B Thakral, G Tang, N Jain, E Jabbour, SA Pierce, ... Modern Pathology 32 (1), 48-58, 2019 | 46 | 2019 |
| A phase II trial of nivolumab combined with ibrutinib for patients with Richter transformation N Jain, A Ferrajoli, S Basu, PA Thompson, JA Burger, TM Kadia, ... Blood 132, 296, 2018 | 38 | 2018 |
| EBV-negative monomorphic B-cell post-transplant lymphoproliferative disorders are pathologically distinct from EBV-positive cases and frequently contain TP53 mutations EL Courville, S Yohe, D Chou, V Nardi, A Lazaryan, B Thakral, AC Nelson, ... Modern Pathology 29 (10), 1200-1211, 2016 | 36 | 2016 |
| Scope and application of therapeutic apheresis: Experience from a tertiary care hospital in North India RR Sharma, K Saluja, A Jain, HK Dhawan, B Thakral, N Marwaha Transfusion and Apheresis Science 45 (3), 239-245, 2011 | 35 | 2011 |
| Extranodal hematopoietic neoplasms and mimics in the head and neck: an update B Thakral, J Zhou, LJ Medeiros Human pathology 46 (8), 1079-1100, 2015 | 31 | 2015 |
| Serial assessment of biochemical parameters of red cell preparations to evaluate safety for neonatal transfusions S Mukherjee, N Marwaha, R Prasad, RR Sharma, B Thakral The Indian Journal of Medical Research 132 (6), 715-720, 2010 | 29 | 2010 |
| Comparison of therapy‐related and de novo core binding factor acute myeloid leukemia: A bone marrow pathology group study HJ Rogers, X Wang, Y Xie, AR Davis, B Thakral, SA Wang, G Borthakur, ... American journal of hematology 95 (7), 799-808, 2020 | 26 | 2020 |
| Ruxolitinib or dasatinib in combination with chemotherapy for patients with relapsed/refractory Philadelphia (Ph)-like acute lymphoblastic leukemia: a phase I-II trial N Jain, EJ Jabbour, PZ McKay, F Ravandi, K Takahashi, T Kadia, ... Blood 130, 1322, 2017 | 26 | 2017 |
| Genomic and immunophenotypic landscape of aggressive NK-cell leukemia S El Hussein, KP Patel, H Fang, B Thakral, S Loghavi, ... The American Journal of Surgical Pathology 44 (9), 1235-1243, 2020 | 24 | 2020 |
Karan SalujaAssociate Professor, UT Health Science Center, Houston, TX在 uth.tmc.edu 的电子邮件经过验证
Karan SalujaAssociate Professor, UT Health Science Center, Houston, TX在 uth.tmc.edu 的电子邮件经过验证
Michael Linden MD PhDUniversity of Minnesota在 umn.edu 的电子邮件经过验证